seed
Stage
1
Investors
About
Lyric Bio develops proprietary tissue-engineered bioreactors to produce human immunoglobulin therapies more efficiently, reducing dependence on plasma donations and improving supply stability.
Explore Lyric Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.